A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age <65 and performance status 2
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7276-7276
Keyword(s):
Stage Iv
◽